Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:440-445
Published online before print December 24, 2007, doi: 10.1161/HYPERTENSIONAHA.107.103093
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
51/2/440    most recent
HYPERTENSIONAHA.107.103093v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghiadoni, L.
Right arrow Articles by Del Prato, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghiadoni, L.
Right arrow Articles by Del Prato, S.
Related Collections
Right arrow Clinical Studies
Right arrow Glucose intolerance
Right arrow Risk Factors

(Hypertension. 2008;51:440.)
© 2008 American Heart Association, Inc.


Original Articles Part 2

Metabolic Syndrome and Vascular Alterations in Normotensive Subjects at Risk of Diabetes Mellitus

Lorenzo Ghiadoni; Giuseppe Penno; Chiara Giannarelli; Yvonne Plantinga; Melania Bernardini; Laura Pucci; Roberto Miccoli; Stefano Taddei; Antonio Salvetti; Stefano Del Prato

From the Department of Internal Medicine (L.G., C.G., Y.P., M.B., S.T., A.S.) and the Department of Endocrinology & Metabolism (G.P., L.P., R.M., S.D.P.), University of Pisa, Italy.

Correspondence to Lorenzo Ghiadoni, MD, PhD, Department of Internal Medicine, University of Pisa, Via Roma, 67, 56100 Pisa, Italy. E-mail l.ghiadoni{at}med.unipi.it

We evaluated the possible association between early vascular abnormalities and the metabolic syndrome (MS) in 77 normotensive subjects (mean age: 50 years) at risk of developing diabetes for family history of diabetes, obesity, or impaired fasting glucose. Fifty healthy subjects were recruited as controls. MS was defined according to the ATP III criteria. Brachial artery endothelium-dependent and -independent vasodilation were assessed as flow-mediated dilation (FMD) and response to glyceryl trinitrate (GTN, 25 µg sublingual), respectively, by automatic computerized edge detection system. Carotid-femoral pulse wave velocity (PWV) and radial augmentation index (AIx) were assessed by applanation tonometry. PWV was significantly (P<0.01) higher in subjects with MS (n=29, 9.0±1.9 m/s) as compared with those without MS (n=48, 7.7±1.2 m/s) and controls (7.2±1.5 m/s). FMD was significantly (P<0.05) reduced in both subjects with (5.8±2.7%) and without MS (6.1±3.7%) as compared with controls (6.9±2.5%). No significant differences were found for response to GTN and AIx. PWV and FMD were significantly (P<0.05) affected by increasing number of MS components. Among the components of the MS, only blood pressure significantly affected PWV, whereas blood pressure and fasting glucose influenced FMD. Logistic regression analysis showed that MS was associated with increased risk of altered PVW (odd ratio: 7.95, confidence limits: 1.06 to 69.11), whereas only blood pressure component was significantly related with increased risk of impaired FMD (odd ratio: 3.60, confidence limits: 1.01 to 12.78). In conclusion, in normotensive subjects at risk of developing diabetes mellitus, the presence of MS is associated with a selective alteration of central PWV.


Key Words: arterial stiffness • pulse wave velocity • endothelium • metabolic syndrome • blood pressure